Elias Animal Health LLC
ELIAS Animal Health is dedicated to transforming cancer treatment for pets by applying state-of-the-art immunotherapy developed for humans. Their mission is to improve cancer treatment outcomes in veterinary patients through innovative therapies, including personalized cancer vaccines and T cell immunotherapy, with the goal of providing effective, less taxing treatment options for animals.
Industries
Nr. of Employees
small (1-50)
Elias Animal Health LLC
Products
Personalized autologous cancer immunotherapy for canine patients
A two-step therapeutic approach combining a personalized tumor-derived vaccine to prime tumor-specific T cells, followed by harvest, ex vivo activation/expansion, and reinfusion of the patient’s own activated T cells.
Personalized autologous cancer immunotherapy for canine patients
A two-step therapeutic approach combining a personalized tumor-derived vaccine to prime tumor-specific T cells, followed by harvest, ex vivo activation/expansion, and reinfusion of the patient’s own activated T cells.
Services
Centralized manufacturing and processing of autologous cell and vaccine therapies
Production, processing, and quality-controlled release of personalized tumor-derived vaccines and activated autologous T-cell products, including logistics for sample transfer between clinics and facility.
Clinical trial design and management for veterinary oncology
Design and conduct of controlled clinical trials in canine cancer, including enrollment, protocol execution, adverse-event monitoring, and comparative outcome analysis.
Apheresis partnership facilitation and clinical collection support
Coordination and partnership with apheresis providers to enable clinical collection of immune cells from patients for downstream processing.
Centralized manufacturing and processing of autologous cell and vaccine therapies
Production, processing, and quality-controlled release of personalized tumor-derived vaccines and activated autologous T-cell products, including logistics for sample transfer between clinics and facility.
Clinical trial design and management for veterinary oncology
Design and conduct of controlled clinical trials in canine cancer, including enrollment, protocol execution, adverse-event monitoring, and comparative outcome analysis.
Apheresis partnership facilitation and clinical collection support
Coordination and partnership with apheresis providers to enable clinical collection of immune cells from patients for downstream processing.
Expertise Areas
- Veterinary immuno-oncology
- Adoptive cell therapy development
- Autologous cell therapy manufacturing and scale-up
- Clinical trial design and execution for veterinary populations
Key Technologies
- Personalized tumor-derived vaccine
- Adoptive autologous T-cell therapy
- Apheresis-based cell collection
- Ex vivo T cell activation and numeric expansion